TR
Trevena, Inc.
TRVN · OTC
$0.00 -70.00% (-$0.00)
1M -70.00%
Market Cap $259.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
P/FFO N/A
Growth
23 /100
Declining Rev. growth 0.60%
EPS growth N/A
Book val. growth N/A
Profitability
19 /100
Weak Gross margin 46.56%
FCF margin 1,058.43%
Net margin 1,289.25%
Quality
1 /100
Poor ROIC 104.42%
Asset turnover 0.08x
ROA 99.22%
Debt
100 /100
Low Current ratio 4.66x
Debt/Equity N/A
Debt/Assets N/A
Stability
25 /100
Unstable Beta -0.41x
Profitable years 0
Rev. volatility 564.93%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TRVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carrie L. Bourdow
Employees
23
Headquarters
Chesterbrook
Nadcházející události
05 LIS
Earnings
Upcoming earnings report